Last 47 quarters of trend data · Healthcare · Medical Devices
Quarterly valuation ratios — annualised for comparability. YoY Δ shows same-quarter-prior-year change.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| P/E Ratio → | -1.05 | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/S Ratio | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| P/B Ratio | 5.21 | 4.84 | 77.98 | 31.08 | 139.78 | 10.11 | 8.11 | 37.19 | 12.93 | 7.84 | 4.61 | 3.88 | 3.05 | 2.25 | — | 16.46 | 5.54 | 1.17 | 1.22 | 1.79 | — |
| — | -52.1% | +861.5% | -16.4% | +981.3% | +29.0% | +75.9% | +858.0% | +323.5% | +248.1% | — | -76.4% | -44.9% | +92.3% | — | +817.9% | — | — | — | — | — | |
| P/FCF | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| EV / EBIT | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Quarterly margins and returns. Watch for margin compression across consecutive quarters.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Operating Margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Net Margin | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | -987.3% | -114.4% | -290.3% | -352.4% | -229.1% | -84.9% | -119.4% | -152.0% | -73.7% | -46.7% | -32.4% | -22.4% | -17.5% | -31.2% | -546.0% | -91.5% | -48.7% | -33.3% | -16.7% | -50.7% | — |
| — | -34.6% | -143.1% | -131.8% | -210.7% | -82.1% | -269.2% | -577.4% | -321.6% | -49.4% | +94.1% | +75.5% | +64.1% | +6.1% | -3161.4% | -80.4% | — | — | — | -29889.0% | — | |
| ROA | -460.9% | -69.2% | -96.2% | -121.6% | -118.7% | -65.9% | -88.6% | -98.8% | -59.3% | -41.7% | -29.9% | -21.1% | -16.8% | -27.3% | -150.4% | -69.3% | -43.6% | -31.4% | -16.1% | -27.9% | -160.3% |
| — | -4.9% | -8.6% | -23.1% | -100.0% | -58.1% | -195.8% | -368.4% | -252.9% | -52.7% | +80.1% | +69.6% | +61.5% | +12.9% | -837.0% | -148.6% | +72.8% | +89.5% | +93.8% | -30942.5% | -346171.9% | |
| ROIC | — | — | — | — | — | -185.9% | -341.7% | — | — | — | — | — | -180.5% | -274.2% | — | — | — | -736.5% | -259.0% | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | +62.8% | — | — | — | — | — | — | — |
Quarterly solvency trend — watch for debt spikes or covenant pressure.
| Metric | TTM | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | Q4 '24 | Q3 '24 | Q2 '24 | Q1 '24 | Q4 '23 | Q3 '23 | Q2 '23 | Q1 '23 | Q4 '22 | Q3 '22 | Q2 '22 | Q1 '22 | Q4 '21 | Q3 '21 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Debt / EBITDA | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| Current Ratio | 1.45 | 3.66 | 0.74 | 1.45 | 0.86 | 2.98 | 5.46 | 1.71 | 3.31 | 6.83 | 12.07 | 14.09 | 19.12 | 37.95 | 0.63 | 2.43 | 7.16 | 12.65 | 24.79 | 23.81 | 0.16 |
| — | +22.7% | -86.4% | -15.3% | -74.0% | -56.4% | -54.8% | -87.9% | -82.7% | -82.0% | +1816.1% | +480.9% | +167.0% | +200.1% | -97.5% | -89.8% | +4479.8% | +11515.1% | +113721.0% | +225636.0% | -94.4% | |
| Quick Ratio | 1.41 | 3.61 | 0.70 | 1.41 | 0.86 | 2.98 | 5.46 | 1.71 | 3.31 | 6.83 | 12.07 | 14.09 | 19.12 | 37.95 | 0.63 | 2.43 | 7.16 | 12.65 | 24.79 | 23.81 | 0.16 |
| — | +21.2% | -87.2% | -17.2% | -74.0% | -56.4% | -54.8% | -87.9% | -82.7% | -82.0% | +1816.1% | +480.9% | +167.0% | +200.1% | -97.5% | -89.8% | +4479.8% | +11515.1% | +113721.0% | +225636.0% | -94.2% | |
| Interest Coverage | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | -1.80 | -0.60 |
| — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
Includes 30+ ratios · 47 years · Updated daily
Live VCP patterns, Cup & Handle overlays, support/resistance, and AI trade plans.
High-probability breakout stocks crossing their pivot across 5 pattern engines.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying BEAT stock.
HeartBeam, Inc.'s current P/E is -1.0x. Quarterly P/E ratios can vary due to seasonal revenue patterns and one-time charges.
Quarterly financial ratios reveal short-term trend shifts — margin compression, debt spikes, or valuation re-ratings — that annual figures smooth over. They're essential for active investors tracking HeartBeam, Inc.'s business trajectory between earnings reports.